Internal Medicine, Rheumatology · Culver City, CA
NPI
1457548133
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9808 Venice Blvd, Ste 604
Culver City, CA, 90232
Phone (310) 204-5555
Groups this clinician bills Medicare through
Medicare paid, 2024
$424K
16,682 services
Medicare patients, 2024
433
Average age 74
Drug cost, 2024
$5.8M
10,444 prescriptions
Company payments, 2025
$5,251
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Solomon N Forouzesh was code J1010 (injection, methylprednisolone acetate, 1 mg), 4,361 times for 67 patients. In total Solomon N Forouzesh billed 16,682 services in 56 codes, and Medicare paid $424K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,361 | 67 | $0.10 | $451 |
| 99213 Office E&M - Established | Office | 2,271 | 364 | $68.67 | $156K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 1,193 | 357 | $25.07 | $30K |
| 99214 Office E&M - Established | Office | 1,054 | 301 | $100.16 | $106K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 969 | 273 | $12.79 | $12K |
| 99211 Office E&M - Established | Office | 860 | 203 | $19.13 | $16K |
| 96372 Injection Administration | Office | 665 | 136 | $11.63 | $7,731 |
| 36415 Venipuncture Blood Collection | Office | 653 | 297 | $8.65 | $5,648 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 138 | 48 | $1.00 | $138 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 105 | 30 | $0.57 | $59.69 |
| 99204 Office E&M - New | Office | 77 | 77 | $122.94 | $9,466 |
| 77080 Standard X-ray | Office | 70 | 67 | $41.28 | $2,889 |
| 72082 X-ray - Spine and Pelvis | Office | 70 | 67 | $58.55 | $4,099 |
| 20610 Joint Injection | Office | 62 | 46 | $52.40 | $3,249 |
| 93000 Electrocardiogram | Office | 43 | 37 | $11.05 | $475 |
By year: 2022 $520K for 7,046 services; 2023 $431K for 8,217 services; 2024 $424K for 16,682 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 653 | 297 | $8.65 | $5,648 |
Medicare prescription drug claims, 2024
In 2024, the drug Solomon N Forouzesh prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 532 prescriptions and refills. In total Solomon N Forouzesh wrote 10,444 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 532 | 725 | 146 | $11K |
| Simvastatin Generic | 325 | 730 | 103 | $1,859 |
| Amlodipine Besylate Generic | 310 | 638 | 76 | $1,116 |
| Methotrexate Methotrexate Sodium | 291 | 365 | 74 | $2,984 |
| Famotidine Generic | 270 | 487 | 91 | $2,078 |
| Gabapentin Generic | 244 | 366 | 65 | $2,868 |
| Prednisone Generic | 209 | 251 | 59 | $1,068 |
| Metformin Hcl Generic | 201 | 381 | 47 | $691 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 180 | 181 | 31 | $1,941 |
| Omeprazole Generic | 167 | 309 | 50 | $1,318 |
| Tramadol Hcl Generic | 160 | 160 | 38 | $560 |
| Lisinopril Generic | 152 | 286 | 34 | $704 |
| Ozempic Semaglutide | 151 | 167 | 28 | $154K |
| Duloxetine Hcl Generic | 147 | 160 | 39 | $2,101 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 142 | 204 | 44 | $603 |
Brand drugs: - claims; generic drugs: 8,396 claims; opioid claims: 480.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Solomon N Forouzesh $5,251 ($5,251 in general payments such as food, travel and fees) from 22 companies. The largest payer was Amgen Inc. with $1,137.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 54 | $1,137 |
| Abbvie Inc. ABBV | 56 | $1,034 |
| GlaxoSmithKline, LLC. GSK | 16 | $455 |
| AstraZeneca Pharmaceuticals LP AZN | 17 | $410 |
| Lilly USA, LLC LLY | 11 | $399 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $373 |
| Janssen Biotech, Inc. JNJ | 13 | $299 |
| UCB, Inc. UCB.BR | 7 | $252 |
| Mallinckrodt Hospital Products Inc. | 10 | $221 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $191 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.